Stryker Received FDA Clearance for Incompass Total Ankle System
On June 25, 2025, Stryker, a global leader in medical technologies, announced that the U.S. Food and Drug Administration (FDA) received 510(k) approval for its Incompass™ Total Ankle System. The implant is designed for patients suffering from severe ankle joint damage due to rheumatoid, post-traumatic, or degenerative arthritis. This next-generation platform unifies key features of Stryker’s Inbone® and Infinity® systems into a single, all-inclusive solution for total ankle replacement.
The Incompass system features Adaptis® Boney Ingrowth Technology and newly designed instrumentation to promo...
